Synthetic molecular probes, chemosensors, and nanosensors used in combination with
innovative assay protocols hold great potential for the development of robust, low-cost, and …

The information obtained from the chemical analysis of specific human excretion products
(biomarkers) in urban wastewater can be used to estimate the exposure or consumption of …

Cell-free DNA shed by cancer cells has been shown to be a rich source of putative tumor-
specific biomarkers. Because cell-free DNA from brain and spinal cord tumors cannot …

To explore the potential of tumor-specific DNA as a biomarker for head and neck squamous
cell carcinomas (HNSCC), we queried DNA from saliva or plasma of 93 HNSCC patients …

The aim of this review was to explore the status of urine sampling as a liquid biopsy for
noninvasive cancer research by reviewing used preanalytical parameters and protocols. We …

Early diagnosis and efficient treatment are of paramount importance to fighting cancers.
Monitoring the foreign body response of a patient to treatment therapies also plays an …

Current non-invasive approaches for detection of urothelial cancers are suboptimal. We
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …

Bladder cancer is a major cause of morbidity, mortality and health-related costs. Urothelial
carcinoma is by far the most common histologic type of bladder cancer and may also arise …

Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are
mirrored in their diverse genomic profiles. Genomic profiling of UBCs has the potential to …

MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …